Proxy Votes Now

Home › Funds › Buffalo Small Cap Growth Fund

Buffalo Small Cap Growth Fund (BUFSX) proxy voting record 2025-2026

Fund family: BUFFALO FUNDS · Filed by BUFFALO FUNDS (CIK 1135300) · SEC series S000022453

Share classes and tickers: BUFSX (C000064614), BUISX (C000214594)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 589 with, 1 against, 14 abstentions (not counted as with management). Shareholder proposals: 0 FOR, 1 AGAINST, 0 abstained, by the filing’s own vote-source field.

Where this fund voted differently from most BUFFALO FUNDS funds

Each ballot item this fund voted is set against the votes of the other BUFFALO FUNDS funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most BUFFALO FUNDS funds on all 7 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 96.2% of this fund’s 604 such votes could be given a sector; the other 23 (3.8%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Consumer Discretionary20000.0%
Health Care11410.9%
Technology8200.0%
Industrials6900.0%
Finance4000.0%
Energy2600.0%
Consumer Staples1200.0%
Miscellaneous1100.0%
Utilities1100.0%
Telecommunications1000.0%
Basic Materials600.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections4180
Say-on-Pay820
Audit-related780
Compensation170
Corporate Governance111
Capital Structure50
Other10
Shareholder Rights and Defenses10

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
LIGAND PHARMACEUTICALS INCORPORATEDJune 5, 2026$18M110
WISDOMTREE, INC.June 17, 2026$16M110
SILICON LABORATORIES INC.April 30, 2026$14M30
SILICON LABORATORIES INC.April 23, 2026$14M50
HINGE HEALTH, INC.June 3, 2026$13M30
CHAMPION HOMES, INC.July 24, 2025$12M100
HALOZYME THERAPEUTICS, INC.May 5, 2026$11M40
PALOMAR HOLDINGS, INC.May 21, 2026$10M40

Notable votes against management

MeetingCompanyProposalFundMgmt
May 15, 2026MEDPACE HOLDINGS, INC.Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposalAgainstFor

Search this fund’s votes by company

613 ballot items at 79 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Buffalo Small Cap Growth Fund (BUFSX) voted at 79 shareholder meetings of 78 companies, on 613 ballot items in all. Where management made a recommendation, the fund followed it on 97.5% of the items and voted against it 1 time. Its most frequent area of disagreement was corporate governance (1 of its votes against management). It voted on 1 shareholder proposal. It voted the same way as most BUFFALO FUNDS funds on every item where a comparison was possible.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.